Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents

By Lees A.   Nelson B.L.   Mond J.J.  

Vaccine, Vol. 14, Iss. 3, 1996-02 ,pp. : 190-198

Elsevier

Access to resources Recommend Favorite

Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccha

By Shafer D.E.   Toll B.   Schuman R.F.   Nelson B.L.   Mond J.J.   Lees A.  

Vaccine, Vol. 18, Iss. 13, 2000-01 ,pp. : 1273-1281

Elsevier

Access to resources Recommend Favorite

Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines

By Plumb J.E.   Yost S.E.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 399-404

Elsevier

Access to resources Recommend Favorite

Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein

By Michon F.   Fusco P.C.   Minetti C.A.S.A.   Laude-Sharp M.   Uitz C.   Huang C.-H.   D'Ambra A.J.   Moore S.   Remeta D.P.   Heron I.   Blake M.S.  

Vaccine, Vol. 16, Iss. 18, 1998-11 ,pp. : 1732-1741

Elsevier

Access to resources Recommend Favorite

Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies

By Pawlowski A.   Kallenius G.   Svenson S.B.  

Vaccine, Vol. 18, Iss. 18, 2000-03 ,pp. : 1873-1885

Elsevier

Access to resources Recommend Favorite